N-Gene Research Laboratories, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Phase 2
Terminated
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: BGP-15 100 mg QDDrug: BGP-15 100 mg BIDDrug: BGP-15 400 mg QDDrug: BGP-15 200 mg QDDrug: BGP-15 200 mg BIDDrug: Placebo BID
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2014-09-29
- Lead Sponsor
- N-Gene Research Laboratories, Inc.
- Target Recruit Count
- 196
- Registration Number
- NCT01069965
- Locations
- 🇺🇸
Andrew J. Lewin Medical Corporation DBA National Research Institute, Los Angeles, California, United States
🇺🇸Center for Clinical Trials, LLC., Paramount, California, United States
🇺🇸Orange County Research Center, Tustin, California, United States
News
No news found